In Brief: Investigator financial disclosure
This article was originally published in The Gray Sheet
Investigator financial disclosure: FDA schedules public hearing for July 20 on its proposed regulation on clinical investigator financial disclosure, which was published Sept. 22, 1994 ("The Gray Sheet" Sept. 26, 1994, p. 12). The hearing will take place in the Wilson Auditorium at the National Institutes of Health campus in Bethesda, Maryland. Those interested in participating may give notice by fax at 301/594-0113...
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.